Synact Pharma | Comment on the EXPAND top line data presented today

00:00 Intro 00:22 Comment to the EXPAND study data - CEO Torbjørn Bjerke 04:00 CSO Thomas Jonassen comments the subjective responses 06:35 The RESOLVE study to be finalized in October, CBO Jim Knight 08:10 What does the EXPAND result mean to Synact.